Inappropriate Shocks in Patients with Fidelis® Lead Fractures: Impact of Remote Monitoring and the Lead Integrity Algorithm

被引:23
作者
Blanck, Zalmen [1 ]
Axtell, Kathi [1 ]
Brodhagen, Kathy [1 ]
O'Hearn, Laura [1 ]
Albelo, Tammy [1 ]
Ceretto, Cheryl [1 ]
Dhala, Anwer [1 ]
Sra, Jasbir [1 ]
Akhtar, Masood [1 ]
机构
[1] Univ Wisconsin, Sch Med & Publ Hlth, Aurora Cardiovasc Serv, Aurora Sinai Aurora St Lukes Med Ctr, Milwaukee, WI 53201 USA
关键词
Fidelis implantable defibrillator lead fracture; implantable cardioverter defibrillator; inappropriate defibrillator shocks; lead integrity algorithm; remote monitoring; wireless CareLink monitoring; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; FAILURE; EFFICACY; SAFETY; ICD;
D O I
10.1111/j.1540-8167.2011.02077.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Prevention of Shocks with Fidelis Lead Fractures. Introduction: The role of remote monitoring combined with lead integrity algorithm (LIA) in patients with Fidelis (Medtronic Inc., Minneapolis, MN, USA) lead fractures is not well defined. Methods: We retrospectively identified patients with Fidelis lead fractures at our institution, documenting all pertinent data (remote monitoring use, clinical presentation, lead fracture diagnosis criteria). Patients were classified into subgroups based on the type of home monitoring and whether LIA was uploaded before lead fracture. Subgroups were compared based on delivery of inappropriate shocks (IS). Results: A total of 131 patients (mean age 62 +/- 16 years, 70% male, 69% primary prevention implants) were followed until lead fracture (average 32 +/- 12 months). IS were delivered in 21% of patients (n = 11/52) with LIA versus 52% (n = 41/79) without LIA, P < 0.001. LIA significantly decreased the number of IS (2.1 +/- 1.0 IS vs 7.9 +/- 12 IS, P < 0.001) and significantly increased the number of patients diagnosed through audible alert (P < 0.001). Wireless monitoring significantly decreased the time interval to reprogram defibrillators OFF (mean 1.5 +/- 1 days vs 15.6 +/- 18 days with nonwireless CareLink [Medtronic Inc.] and 12.4 +/- 20 days without CareLink, P < 0.001); 14% of patients with LIA and wireless monitoring combined received IS. Without LIA, 63% of patients with wireless monitoring received IS. Conclusion: This study confirms that LIA significantly decreases IS therapy in patients with Fidelis lead fractures. Wireless technology enhances LIA benefits by significantly shortening time to reprogram defibrillators. However, despite the "best scenario" of combining LIA and wireless monitoring, 14% of patients with lead fractures still get IS. Further refinements of detection algorithms are required to eliminate this significant clinical problem. (J Cardiovasc Electrophysiol, Vol. 22, pp. 1107-1114, October 2011)
引用
收藏
页码:1107 / 1114
页数:8
相关论文
共 29 条
[1]   Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure [J].
Bardy, GH ;
Lee, KL ;
Mark, DB ;
Poole, JE ;
Packer, DL ;
Boineau, R ;
Domanski, M ;
Troutman, C ;
Anderson, J ;
Johnson, G ;
McNulty, SE ;
Clapp-Channing, N ;
Davidson-Ray, LD ;
Fraulo, ES ;
Fishbein, DP ;
Luceri, RM ;
Ip, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) :225-237
[2]   Sensing lead failure in implantable defibrillators: A comparison of two commonly used leads [J].
Degeratu, FT ;
Khalighi, K ;
Peters, RW ;
Shorofsky, SR ;
Gold, MR .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2000, 11 (01) :21-24
[3]   Transvenous defibrillation leads: High incidence of failure during long-term follow-up [J].
Dorwarth, U ;
Frey, B ;
Dugas, M ;
Matis, T ;
Fiek, M ;
Schmoeckel, M ;
Remp, T ;
Durchlaub, I ;
Gerth, A ;
Steinbeck, G ;
Hoffmann, E .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2003, 14 (01) :38-43
[4]   Detection and management of an implantable cardioverter defibrillator lead failure - Incidence and clinical implications [J].
Ellenbogen, KA ;
Wood, MA ;
Shepard, RK ;
Clemo, HF ;
Vaughn, T ;
Holloman, K ;
Dow, M ;
Leffler, J ;
Abeyratne, A ;
Verness, D .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (01) :73-80
[5]  
Engel Gregory, 2008, Congest Heart Fail, V14, P14
[6]   Accelerating risk of Fidelis lead fracture [J].
Farwell, David ;
Green, Martin S. ;
Lemery, Robert ;
Gollob, Michael H. ;
Birnie, David H. .
HEART RHYTHM, 2008, 5 (10) :1375-1379
[7]   An algorithm to predict implantable cardioverter-defibrillator lead failure [J].
Gunderson, BD ;
Patel, AS ;
Bounds, CA ;
Shepard, RK ;
Wood, MA ;
Ellenbogen, KA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (09) :1898-1902
[8]   Early failure of a small-diameter high-voltage implantable cardioverter-defibrillator lead [J].
Hauser, Robert G. ;
Kallinen, Linda M. ;
Almquist, Adrian K. ;
Gornick, Charles C. ;
Katsiyiannis, William T. .
HEART RHYTHM, 2007, 4 (07) :892-896
[9]   Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure [J].
Hauser, Robert G. ;
Hayes, David L. .
HEART RHYTHM, 2009, 6 (05) :605-610
[10]   Failure of impedance monitoring to prevent adverse clinical events caused by fracture of a recalled high-voltage implantable cardioverter-defibrillator lead [J].
Kallinen, Linda M. ;
Hauser, Robert G. ;
Lee, Ken W. ;
Almquist, Adrian K. ;
Katsiyiannis, William T. ;
Tang, Chuen Y. ;
Melby, Daniel P. ;
Gornick, Charles C. .
HEART RHYTHM, 2008, 5 (06) :775-779